BEXIMCO PHARMACEUTICALS
19 Feb 2018
Northland Capital Partners Limited Morning Report
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Northland Capital Partners Limited Morning Report
Beximco Pharmaceuticals Limited Sponsored GDR RegS (BXP:LON) | 37.0 0.2 1.4% | Mkt Cap: 165.1m
- Published:
19 Feb 2018 -
Author:
Vadim Alexandre -
Pages:
31
BEXIMCO PHARMACEUTICALS